Select your language/region

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

0.0743

SEK

-2.11

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

0.0743

SEK

-2.11

percent

Redeye Theme: Medtech Presentation

Our CEO, Stuart Gander, presented at the Redeye Theme: Medtech event on May 8th, 2025.

You can watch the presentation here.

Life Science Day Presentation

Our CEO Stuart Gander presented at Life Science Day courtesy of Aktiespararna on the 17th of April 2024.

Watch the presentation here:

 

 

Future-proof Healthcare

One of our founders, Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Regulatory press release

2025/06/26

BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Press release

2025/06/19

Q-linea on track for 2025 plan

Regulatory press release

2025/05/30

New number of shares and votes in Q-linea AB (publ)
The number of shares and votes in Q-linea AB (publ) (the “Company”) has increased during May as a result…
Read more >

Keep up to date – subscribe

Christer Samuelsson

Investor Relations

Phone: +46 18 444 36 10

Mobile: +46 70 600 15 20

christer.samuelsson@qlinea.com

. . .
The share

Information about Q-linea stock price and trading volume